Abstract
AbstractRecurrent pregnancy loss (RPL) is a one of the most common obstetrical complications. Since, the successful pregnancy occurs in T helper 2 (Th2)‐dominant situation and since, Th1 type immunity is related to pregnancy failure, we investigated the effects of cyclosporine on Th1 and Th2 cells in RPL women. Totally, 76 RPL patients (38 women as treated group and 38 as control group) were included in this study. Flow cytometry was utilized to analyze the frequency of Th1 and Th2 in blood samples. Also, real‐time polymerase chain reaction was carried out to assess the messenger RNA (mRNA) expression of transcription factors and enzyme‐linked immunosorbent assay was used to evaluate Th1 and Th2 related cytokines. Significant decrease in Th1 frequency (p = 0.0004), Th1/Th2 ratio (p < 0.0001), T‐bet mRNA expression (p < 0.0001), interferon‐γ (p = 0.0007), and tumor necrosis factor α (p = 0.0002) secretion level were observed in cyclosporine group. Moreover, significant increase in Th2 frequency (p < 0.0001), mRNA expression of GATA binding protein 3 (p = 0.0001), and interleukin 10 secretion level (p = 0.0027) was also evident in treated group. At the end of the investigation, 31 (81.5%) patients in cyclosporine‐treated group had successful childbirth when compared with 16 (42.1%) women in control group (p = 0.0001). Given this, cyclosporine treatment for RPL patients with elevated Th1/Th2 ratio can result in improved pregnancy outcome.
Topics

No keywords indexed for this article. Browse by subject →

References
43
[5]
Borel J. F. "History of the discovery of cyclosporin and of its early pharmacological development" Wiener Klinische Wochenschrift (2002)
[6]
Bourget P. "Transplacental passage of cyclosporine after liver transplantation" Transplantation (1990)
[9]
First M. "Cyclosporine bioavailability: Dosing implications and impact on clinical outcomes in select transplantation subpopulations" Clinical Transplantation (1996)
[10]
Ford H. B. "Recurrent pregnancy loss: etiology, diagnosis, and therapy" Reviews in obstetrics and gynecology (2009)
[14]
Huynh L. A. "Outcomes of pregnancy and the management of immunosuppressive agents to minimize fetal risks in organ transplant patients" The Annals of Pharmacotherapy (1994)
[21]
Olshan A. "International Commission for Protection Against Environmental Mutagens and Carcinogens. Cyclosporine A: review of genotoxicity and potential for adverse human reproductive and developmental effects" Report of a Working Group on the genotoxicity of cyclosporine A, August 18, 1993 (1994)
[33]
Analyzing real-time PCR data by the comparative CT method

Thomas D Schmittgen, Kenneth J Livak

Nature Protocols 10.1038/nprot.2008.73
[35]
Sykes L. "The Th1: Th2 dichotomy of pregnancy and preterm labour" Mediators of Inflammation (2012) 10.1155/2012/967629
[36]
Tang C. "Cyclosporin A enhances the ability of trophoblasts to displace the activated human umbilical vein endothelial cell monolayers" International Journal of Clinical and Experimental Pathology (2013)
[40]
Wang S.‐C. "Cyclosporin A promotes proliferating cell nuclear antigen expression and migration of human cytotrophoblast cells via the mitgen‐activated protein kinase‐3/1‐mediated nuclear factor‐κB signaling pathways" International Journal of Clinical and Experimental Pathology (2013)
[42]
Weigmann B. "A mechanism of action for cyclosporine a in ulcerative colitis: The role of the tec kinase itk in disease pathogenesis" Gastroenterology (2017) 10.1016/s0016-5085(17)32632-x
[43]
Østensen M. "Update on safety during pregnancy of biological agents and some immunosuppressive anti‐rheumatic drugs" Rheumatology (2008)
Metrics
58
Citations
43
References
Details
Published
Mar 28, 2019
Vol/Issue
234(10)
Pages
19039-19047
License
View
Authors
Funding
Tabriz University of Medical Sciences
Cite This Article
Ramyar Azizi, Majid Ahmadi, Shahla Danaii, et al. (2019). Cyclosporine A improves pregnancy outcomes in women with recurrent pregnancy loss and elevated Th1/Th2 ratio. Journal of Cellular Physiology, 234(10), 19039-19047. https://doi.org/10.1002/jcp.28543
Related

You May Also Like

Macrophage plasticity, polarization, and function in health and disease

Abbas Shapouri‐Moghaddam, Saeed Mohammadian · 2018

4,245 citations

An overview of microRNAs: Biology, functions, therapeutics, and analysis methods

Kioomars Saliminejad, Hamid Reza Khorram Khorshid · 2018

1,747 citations

Cyclooxygenase‐2 in cancer: A review

Nasser Hashemi Goradel, Masoud Najafi · 2018

666 citations

PAI‐1 in tissue fibrosis

Asish K. Ghosh, Douglas E. Vaughan · 2011

595 citations